Primary biliary cirrhosis and Sjögren's syndrome: Autoimmune epithelitis

Carlo Selmi, Pier Luigi Meroni, M. Eric Gershwin

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

Primary biliary cirrhosis (PBC) has been often coined a model autoimmune disease based on the homogeneity amongst patients, the frequency and similarity of antimitochondrial antibodies, including the highly directed immune response to pyruvate dehydrogenase (PDC-E2). A significant number of patients with PBC suffer from sicca and amongst these, there are patients who also have classic Sjögren's syndrome. Indeed, both PBC and Sjögren's syndrome are characterized by inflammation of target epithelial elements. Both diseases can be considered on the basis of a number of other related clinical aspects, including proposed unique apoptotic features of the target tissue, the role of secretory IgA, and the frequency with which both diseases overlap with each other. Indeed, PBC may be considered a Sjögren's syndrome of the liver, whereas Sjögren's syndrome can be equally discussed as PBC of the salivary glands. Dissection of the genetic predispositions for both diseases and especially the molecular basis of effector mechanisms, will become critical elements in developing new therapies.

Original languageEnglish (US)
Pages (from-to)34-42
Number of pages9
JournalJournal of Autoimmunity
Volume39
Issue number1-2
DOIs
StatePublished - Aug 2012

Fingerprint

Biliary Liver Cirrhosis
Secretory Immunoglobulin A
Genetic Predisposition to Disease
Salivary Glands
Pyruvic Acid
Autoimmune Diseases
Dissection
Oxidoreductases
Inflammation
Antibodies
Liver

Keywords

  • Apoptosis
  • Autoantibodies
  • Epithelium
  • Inflammation

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Primary biliary cirrhosis and Sjögren's syndrome : Autoimmune epithelitis. / Selmi, Carlo; Meroni, Pier Luigi; Gershwin, M. Eric.

In: Journal of Autoimmunity, Vol. 39, No. 1-2, 08.2012, p. 34-42.

Research output: Contribution to journalArticle

Selmi, Carlo ; Meroni, Pier Luigi ; Gershwin, M. Eric. / Primary biliary cirrhosis and Sjögren's syndrome : Autoimmune epithelitis. In: Journal of Autoimmunity. 2012 ; Vol. 39, No. 1-2. pp. 34-42.
@article{167585e1979e4ad29c1351ae7d959d1f,
title = "Primary biliary cirrhosis and Sj{\"o}gren's syndrome: Autoimmune epithelitis",
abstract = "Primary biliary cirrhosis (PBC) has been often coined a model autoimmune disease based on the homogeneity amongst patients, the frequency and similarity of antimitochondrial antibodies, including the highly directed immune response to pyruvate dehydrogenase (PDC-E2). A significant number of patients with PBC suffer from sicca and amongst these, there are patients who also have classic Sj{\"o}gren's syndrome. Indeed, both PBC and Sj{\"o}gren's syndrome are characterized by inflammation of target epithelial elements. Both diseases can be considered on the basis of a number of other related clinical aspects, including proposed unique apoptotic features of the target tissue, the role of secretory IgA, and the frequency with which both diseases overlap with each other. Indeed, PBC may be considered a Sj{\"o}gren's syndrome of the liver, whereas Sj{\"o}gren's syndrome can be equally discussed as PBC of the salivary glands. Dissection of the genetic predispositions for both diseases and especially the molecular basis of effector mechanisms, will become critical elements in developing new therapies.",
keywords = "Apoptosis, Autoantibodies, Epithelium, Inflammation",
author = "Carlo Selmi and Meroni, {Pier Luigi} and Gershwin, {M. Eric}",
year = "2012",
month = "8",
doi = "10.1016/j.jaut.2011.11.005",
language = "English (US)",
volume = "39",
pages = "34--42",
journal = "Journal of Autoimmunity",
issn = "0896-8411",
publisher = "Academic Press Inc.",
number = "1-2",

}

TY - JOUR

T1 - Primary biliary cirrhosis and Sjögren's syndrome

T2 - Autoimmune epithelitis

AU - Selmi, Carlo

AU - Meroni, Pier Luigi

AU - Gershwin, M. Eric

PY - 2012/8

Y1 - 2012/8

N2 - Primary biliary cirrhosis (PBC) has been often coined a model autoimmune disease based on the homogeneity amongst patients, the frequency and similarity of antimitochondrial antibodies, including the highly directed immune response to pyruvate dehydrogenase (PDC-E2). A significant number of patients with PBC suffer from sicca and amongst these, there are patients who also have classic Sjögren's syndrome. Indeed, both PBC and Sjögren's syndrome are characterized by inflammation of target epithelial elements. Both diseases can be considered on the basis of a number of other related clinical aspects, including proposed unique apoptotic features of the target tissue, the role of secretory IgA, and the frequency with which both diseases overlap with each other. Indeed, PBC may be considered a Sjögren's syndrome of the liver, whereas Sjögren's syndrome can be equally discussed as PBC of the salivary glands. Dissection of the genetic predispositions for both diseases and especially the molecular basis of effector mechanisms, will become critical elements in developing new therapies.

AB - Primary biliary cirrhosis (PBC) has been often coined a model autoimmune disease based on the homogeneity amongst patients, the frequency and similarity of antimitochondrial antibodies, including the highly directed immune response to pyruvate dehydrogenase (PDC-E2). A significant number of patients with PBC suffer from sicca and amongst these, there are patients who also have classic Sjögren's syndrome. Indeed, both PBC and Sjögren's syndrome are characterized by inflammation of target epithelial elements. Both diseases can be considered on the basis of a number of other related clinical aspects, including proposed unique apoptotic features of the target tissue, the role of secretory IgA, and the frequency with which both diseases overlap with each other. Indeed, PBC may be considered a Sjögren's syndrome of the liver, whereas Sjögren's syndrome can be equally discussed as PBC of the salivary glands. Dissection of the genetic predispositions for both diseases and especially the molecular basis of effector mechanisms, will become critical elements in developing new therapies.

KW - Apoptosis

KW - Autoantibodies

KW - Epithelium

KW - Inflammation

UR - http://www.scopus.com/inward/record.url?scp=84862491289&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862491289&partnerID=8YFLogxK

U2 - 10.1016/j.jaut.2011.11.005

DO - 10.1016/j.jaut.2011.11.005

M3 - Article

C2 - 22178199

AN - SCOPUS:84862491289

VL - 39

SP - 34

EP - 42

JO - Journal of Autoimmunity

JF - Journal of Autoimmunity

SN - 0896-8411

IS - 1-2

ER -